HK1042657A1 - 預防腹瀉病原菌的乳杆菌菌株 - Google Patents

預防腹瀉病原菌的乳杆菌菌株 Download PDF

Info

Publication number
HK1042657A1
HK1042657A1 HK02104517.4A HK02104517A HK1042657A1 HK 1042657 A1 HK1042657 A1 HK 1042657A1 HK 02104517 A HK02104517 A HK 02104517A HK 1042657 A1 HK1042657 A1 HK 1042657A1
Authority
HK
Hong Kong
Prior art keywords
pathogenic bacteria
lactobacillus strains
diarrhoea caused
preventing diarrhoea
caused pathogenic
Prior art date
Application number
HK02104517.4A
Other languages
English (en)
Chinese (zh)
Inventor
Neeser Jean-Richard
Reniero Roberto
Servin Alain
Original Assignee
Societe Des Produits Nestle S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Des Produits Nestle S.A. filed Critical Societe Des Produits Nestle S.A.
Publication of HK1042657A1 publication Critical patent/HK1042657A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/36—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G9/363—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • Cereal-Derived Products (AREA)
HK02104517.4A 1999-03-11 2000-03-02 預防腹瀉病原菌的乳杆菌菌株 HK1042657A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99104922A EP1034787A1 (en) 1999-03-11 1999-03-11 Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
EP99104922.2 1999-03-11
PCT/EP2000/001795 WO2000053200A1 (en) 1999-03-11 2000-03-02 Lactobacillus strains preventing diarrhoea pathogenic bacteria

Publications (1)

Publication Number Publication Date
HK1042657A1 true HK1042657A1 (zh) 2002-08-23

Family

ID=8237746

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104517.4A HK1042657A1 (zh) 1999-03-11 2000-03-02 預防腹瀉病原菌的乳杆菌菌株

Country Status (23)

Country Link
US (1) US6835376B1 (https=)
EP (2) EP1034787A1 (https=)
JP (1) JP2002537865A (https=)
CN (1) CN1350461A (https=)
AR (1) AR022912A1 (https=)
AU (1) AU779414B2 (https=)
BR (1) BR0008911A (https=)
CA (1) CA2364435A1 (https=)
CO (1) CO5241327A1 (https=)
CZ (1) CZ20013264A3 (https=)
HK (1) HK1042657A1 (https=)
HU (1) HUP0200205A3 (https=)
ID (1) ID30438A (https=)
IL (2) IL145079A0 (https=)
MY (1) MY125941A (https=)
NO (1) NO20014299L (https=)
NZ (1) NZ513806A (https=)
PE (1) PE20001557A1 (https=)
PL (1) PL355226A1 (https=)
RO (1) RO121701B1 (https=)
RU (2) RU2243779C2 (https=)
WO (1) WO2000053200A1 (https=)
ZA (2) ZA200107293B (https=)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
EP1290136B1 (en) * 2000-05-25 2006-05-10 Société des Produits Nestlé S.A. Probiotics for pet food applications
SE0003100D0 (sv) * 2000-09-01 2000-09-01 Probi Ab New strains
SE0003576D0 (sv) * 2000-10-04 2000-10-04 Probi Ab New strain
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
SE0103695D0 (sv) 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
DK1485463T3 (da) 2002-03-21 2008-11-10 Bifodan As Lactobacillus stamme
JP4308481B2 (ja) * 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 抗アレルギー剤
SI1565547T2 (sl) 2002-06-28 2013-02-28 Biosearch S.A. Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
JP2004189672A (ja) * 2002-12-11 2004-07-08 Gen Corp:Kk 抗下痢症組成物
CN1767839B (zh) * 2003-03-13 2012-08-22 麒麟控股株式会社 抗过敏的组合物
WO2004087891A1 (en) * 2003-04-02 2004-10-14 Axcan Pharma S.A. Lactobacillus fermentum strain and uses thereof
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
ITRM20040166A1 (it) * 2004-03-31 2004-06-30 Alberto Cresci Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
TW200637908A (en) * 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
WO2006108824A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US20060263311A1 (en) * 2005-05-19 2006-11-23 Scavone Timothy A Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
AU2006297896B2 (en) * 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
CA2642431A1 (en) 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
CA2644968A1 (en) 2006-03-07 2007-09-13 Nestec S.A. Synbiotic mixture
EP1952703B1 (de) * 2007-02-02 2010-08-25 May, Amadeus Alexander Produkt mit lebenden probiotischen Mikroorganismen
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
WO2009008717A1 (en) * 2007-07-06 2009-01-15 N.V. Nutricia Use of probiotics and fibers for diarrhoea
US20090110663A1 (en) * 2007-10-24 2009-04-30 Halow George M Method for treatment of bowel disorders
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
PL2244593T3 (pl) 2008-01-24 2015-11-30 Nestec Sa Kapsułka zawierająca składniki odżywcze i sposób dostarczania cieczy odżywczej z kapsułki
SG188887A1 (en) 2008-03-14 2013-04-30 Nestec Sa Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
DK2166083T3 (da) * 2008-12-31 2011-03-28 Syngen Biotech Co Ltd Ny Lactobacillus paracasei subsp. paracasei SG96, bakteriostatisk sammensætning indeholdende denne og anvendelse heraf
US20100196341A1 (en) * 2009-02-05 2010-08-05 Syngen Biotech Co., Ltd. Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
SG173832A1 (en) 2009-02-24 2011-09-29 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
AU2010329990B2 (en) 2009-12-08 2015-07-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
EP2734049B1 (en) 2011-06-20 2018-05-02 H.J. Heinz Company Brands LLC Probiotic compositions and methods
ES3010649T3 (en) 2012-06-18 2025-04-04 Heinz Co Brands H J Llc Gluten-related disorders
NZ714202A (en) 2013-05-10 2021-07-30 Heinz Co Brands H J Llc Probiotics and methods of use
SG11201704543XA (en) 2014-12-05 2017-07-28 Synlogic Inc Bacteria engineered to treat diseases associated with hyperammonemia
US10610546B2 (en) 2015-05-13 2020-04-07 Synlogic Operating Company Inc. Bacteria engineered to reduce hyperphenylalaninemia
CN107208044B (zh) 2014-12-05 2021-08-13 同生运营公司 被工程化为治疗与高氨血症相关的疾病的细菌
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
BR112017018656B1 (pt) 2015-03-02 2021-11-30 Synlogic, Inc Bactéria geneticamente modificada, composição farmaceuticamente aceitável compreendendo a dita bactéria e uso da dita composição para tratar ou prevenir uma doença ou condição associada à inflamação intestinal e/ou função da barreira intestinal comprometida
EP3294757B1 (en) 2015-05-13 2023-12-27 Synlogic Operating Company, Inc. Bacteria engineered to treat a disease or disorder
AU2016274311A1 (en) 2015-06-10 2018-01-18 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2016210373A2 (en) 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
WO2016210378A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Multi-layered control of gene expression in genetically engineered bacteria
WO2016210384A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
EP3328988A1 (en) 2015-07-31 2018-06-06 Synlogic, Inc. Bacteria engineered to treat disorders involving propionate catabolism
EP3344266A1 (en) 2015-08-31 2018-07-11 Synlogic, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
AU2016346646B2 (en) 2015-10-30 2022-12-01 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017075485A1 (en) 2015-10-30 2017-05-04 Synlogic, Inc. Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
WO2017087580A1 (en) 2015-11-16 2017-05-26 Synlogic, Inc. Bacteria engineered to reduce hyperphenylalaninemia
WO2017123675A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
WO2017123676A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
WO2017123610A2 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to detoxify deleterious molecules
WO2017123592A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat disorders associated with bile salts
WO2017123418A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
WO2017136795A1 (en) 2016-02-04 2017-08-10 Synlogic, Inc. Bacteria engineered to treat diseases associated with tryptophan metabolism
WO2017136792A2 (en) 2016-02-04 2017-08-10 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017139708A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
WO2017139697A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
DK3454675T3 (da) * 2016-05-11 2026-03-16 Chr Hansen As Mælkesyrebakterier til et varmebehandlet fødevareprodukt til opbevaring ved stuetemperatur
JP2020505016A (ja) 2017-01-06 2020-02-20 シンロジック オペレーティング カンパニー インコーポレイテッド 腫瘍細胞において免疫モジュレーターおよび抗がん治療剤を産生するようにプログラムされた微生物
US10941433B2 (en) 2017-06-15 2021-03-09 Iowa State University Research Foundation, Inc. Neurotransmitter transport in probiotics
CN111655841A (zh) 2017-06-21 2020-09-11 同生运营公司 用于治疗紊乱的细菌
CN111246865A (zh) 2017-07-12 2020-06-05 同生运营公司 程序化以在肿瘤细胞中产生免疫调节剂和抗癌治疗剂的微生物
WO2019090101A1 (en) 2017-11-03 2019-05-09 Synlogic Operating Company, Inc. Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
EP3822338A4 (en) 2018-09-30 2021-08-18 Inner Mongolia Yili Industrial Group Co., Ltd. LACTOBACILLUS PARACASEI ET-22 AND ITS USE
CN110960559B (zh) * 2018-09-30 2021-02-26 内蒙古伊利实业集团股份有限公司 用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
WO2020223345A1 (en) 2019-04-29 2020-11-05 Antipov Eugene Enumeration of genetically engineered microorganisms by live cell counting techniques
CN114144078B (zh) 2019-07-23 2024-06-11 菲仕兰坎皮纳荷兰公司 包含乳脂肪和免疫球蛋白的营养组合物
TW202126317A (zh) 2019-09-24 2021-07-16 美商普拉塔生技公司 用於治療發炎和免疫疾病之組成物和方法
EP4081229B1 (en) 2019-12-24 2026-02-25 Iowa State University Research Foundation, Inc. Control of histamine to increase feeding efficiency and treat or prevent preventing and/or treating clostridial dermatitis and/or clostridial enteric disease using brevibacterium aureum, brevibacterium sediminis, and/or brevibacterium epidermidis
CN113355252A (zh) * 2020-03-06 2021-09-07 南京卫岗乳业有限公司 一种副干酪乳杆菌及其应用
CN115298308A (zh) 2020-03-20 2022-11-04 同生运营公司 经工程化以减轻高苯丙氨酸血症的微生物
CA3188645A1 (en) 2020-08-14 2022-02-17 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies
WO2022120028A2 (en) 2020-12-02 2022-06-09 Synlogic Operating Company, Inc. Engineered microorganisms
US20240316121A1 (en) 2020-12-31 2024-09-26 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia
EP4277634A1 (en) 2021-01-12 2023-11-22 Prolacta Bioscience, Inc. Synbiotic treatment regimens
CN112625983B (zh) * 2021-03-05 2021-05-28 山东中科嘉亿生物工程有限公司 一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
CN112877260B (zh) * 2021-03-30 2022-08-09 江南大学 一株缓解泻剂结肠的副干酪乳杆菌及其应用
WO2022221273A1 (en) 2021-04-13 2022-10-20 Synlogic Operating Company, Inc. Bacteria engineered to secrete active proteins
CN115671144A (zh) * 2021-07-26 2023-02-03 锦乔生物科技有限公司 使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
WO2023044479A1 (en) 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
WO2023245171A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
WO2023245168A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
US20230414679A1 (en) 2022-06-22 2023-12-28 Iowa State University Research Foundation, Inc. Control of histamine to promote health and control enterocolitis using probiotic compositions
CA3260276A1 (en) 2022-06-23 2023-12-28 Michael James Genetically modified recombinant bacteria for treating diseases associated with methionine metabolism and associated methods of use
WO2024081768A1 (en) 2022-10-12 2024-04-18 Synlogic Operating Company, Inc. Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
EP4605522A1 (en) 2022-10-17 2025-08-27 Synlogic Operating Company, Inc. Recombinant bacteria expressing phenylalanine ammonia lyase, phenylalanine transporter and l- aminoacid deaminase for reducing hyperphenylalaninemia
WO2024129974A1 (en) 2022-12-14 2024-06-20 Synlogic Operating Company, Inc. Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production
EP4647439A1 (en) 2024-05-09 2025-11-12 Alma Mater Studiorum - Università di Bologna Non-pathogenic bacteria for delivery of ptd-fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
EP0768375B2 (fr) * 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Bactérie lactique
CA2191213C (en) * 1994-05-26 2008-03-18 Lorenzo Morelli Lactobacillus strains of human origin, their compositions and uses thereof
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
CN1244684C (zh) * 1999-03-11 2006-03-08 雀巢制品公司 能够预防病原细菌和轮状病毒引起的腹泻的乳杆菌菌株

Also Published As

Publication number Publication date
EP1034787A1 (en) 2000-09-13
ID30438A (id) 2001-12-06
JP2002537865A (ja) 2002-11-12
US6835376B1 (en) 2004-12-28
EP1162986A1 (en) 2001-12-19
CO5241327A1 (es) 2003-01-31
PL355226A1 (en) 2004-04-05
PE20001557A1 (es) 2001-02-01
AR022912A1 (es) 2002-09-04
NO20014299D0 (no) 2001-09-04
CA2364435A1 (en) 2000-09-14
RO121701B1 (ro) 2008-02-28
BR0008911A (pt) 2002-01-15
CZ20013264A3 (cs) 2002-01-16
NZ513806A (en) 2003-08-29
IL145079A (en) 2006-08-01
ZA200107293B (en) 2003-02-26
WO2000053200A1 (en) 2000-09-14
CN1350461A (zh) 2002-05-22
AU779414B2 (en) 2005-01-20
NO20014299L (no) 2001-11-05
RU2247569C2 (ru) 2005-03-10
MY125941A (en) 2006-09-29
IL145079A0 (en) 2002-06-30
HUP0200205A3 (en) 2002-06-28
ZA200107290B (en) 2003-02-26
HUP0200205A2 (hu) 2002-05-29
RU2243779C2 (ru) 2005-01-10
AU3162700A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
HK1042657A1 (zh) 預防腹瀉病原菌的乳杆菌菌株
HK1046929A1 (zh) 预防病原性细菌引起的腹泻的双歧杆菌
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
CA2191213A1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
CA2316888A1 (en) Methods of inactivating bacteria including bacterial spores
CA2249361A1 (en) Enhancement of microbial colonisation of the gastrointestinal tract
AU3162900A (en) Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
AU3683900A (en) Biological addition to organic-mineral fertilizers
EP1347060A4 (en) METHOD FOR DETECTION OF A PATHOGENIC MICROORGANISM
EP1854363B8 (en) Fermented tea beverage and tea beverage
AU6373501A (en) Preparation that contains the intestinal beneficial bacterium fermentation culture
AU2745597A (en) Detergent compositions comprising modified polyamines as dye transfer inhibitors
AU6901501A (en) Non-viable lactobacillus containing food product
AU2002333278A1 (en) Solid composition containing Bacillus-type non-pathogenic bacterial spores
CA2142946A1 (en) Low buffer nutritional composition
HUP0402024A3 (en) Solid composition containing bacillus-type non-pathogenic bacterial spores
CA2388952A1 (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
AU7498896A (en) Lactic starters and use thereof for preparing cholesterol-lowering products
AU4925200A (en) Oral composition containing perlite
WO2000028943A3 (fr) Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
WO2000015042A3 (en) Dairy product and method for preparing same
AU3550599A (en) Enterotoxin-deficient bacillus
AU5069500A (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
KR960003597A (ko) 유산균 변이주를 이용한 발효 알로에 베라겔의 제조방법
RU97113193A (ru) Штамм бактерий bacillus anthracis 81/1, используемый в качестве тест-заражающей культуры